Ignyta collaborates with Leiden University Medical Center for rheumatoid arthritis research
Ignyta chairman, CEO, co-founder and MD Jonathan Lim said the collaboration with LUMC will enable Ignyta to study patients with undifferentiated arthritis and rheumatoid arthritis, taking the company
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.